it can affect your health, energy, and overall well-being
Additionally, in December 2024, Zepbound gained FDA approval for treating moderate to severe obstructive sleep apnea (OSA) in adults with obesity
33K Views 20 Posts $Eli Lilly and Co (LLY.US)$ reports first-quarter 2026 earnings on April 30, and this print will be less about whether demand for GLP-1 drugs is strong
Understanding the stability of a reconstituted peptide isn't just about following a simple rule
2 / 7 Medisafe Medisafe takes the mental load out of shot day
Scenario 1: Private Insurance with Manufacturer Program Profile: 45-year-old with employer-provided insurance (Sun Life), BMI 35, type 2 diabetes Coverage: Insurance approves after prior authorization, covers 70% after $500 deductible Calculation: Annual retail cost: $21,000 Deductible: $500 Insurance pays 70% of remaining $20,500 = $14,350 Patient owes: $6,650 Manufacturer program saves: $2,800 Final patient cost: $3,850 annually ($320/month) Verdict: Most affordable scenario
